ARCHIVES

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

This article is from The Cancer Letter archive.

Vol. 06 No. 08 | February 22, 1980

Download PDF Visit The Full Archive

Related Articles

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

January 22, 1993

NCI Directory Delayed

January 27, 1984

Organ Site Grants Fare Badly In NIH Study Section Review; RPMI, UT Galveston, Rush Compete For HQ

October 21, 1983

In Brief: New Greg For Surgery Research Approved; Only 30 Bioassay Program Reports Still In Backlog

April 21, 1978

NCI Chief Operating Officer Lawrence Ray To Retire

April 24, 2009

MicroRNA Biomarkers Linked To Early-Stage Prostate Cancer

February 24, 2012